Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To measure meropenem pancreatic tissue penetration in subjects with severe pancreatitis
requiring surgery between 30 to 60 minutes after a bolus of 1 g IV meropenem given during the
induction period of anesthesia.